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Lower Residual Renal Function is a Risk Factor for Depression 
and Impaired Health-Related Quality of Life in Korean Peritoneal 
Dialysis Patients
We retrospectively evaluated demographic and biochemical parameters associated with 
depression and health-related quality of life (HRQOL) in maintenance peritoneal dialysis 
(PD) patients. This study included 105 patients maintaining PD at Seoul National University 
Hospital. Data were collected from electronic medical record. Korean Beck’s Depression 
Inventory and Korean version of Kidney Disease Quality of Life short form, version 1.3 were 
used to evaluate depression and HRQOL, respectively. Moderate to severe depression was 
found in 24.8% of patients. Patients with lower normalized protein equivalent of nitrogen 
appearance (nPNA) (< 1.2 g/kg/day), lower weekly renal Kt/Vurea (< 0.2), and lower serum 
albumin level (≤ 4.0 g/dL) were associated with depression (P < 0.05). Among them, lower 
weekly renal Kt/Vurea was the only independent risk factor associated with depression 
(OR = 3.1, P = 0.007). Depressed patients showed significantly lower scores in every 
dimension of HRQOL (P < 0.001). Lower weekly renal Kt/Vurea (β = 0.24, P = 0.005) and 
lower nPNA (β = 0.15, P = 0.03) were the independent risk factors associated with lower 
kidney dialysis component summary, whereas lower plasma hemoglobin level was the 
consistent risk factor for lower physical component summary (β = 0.22, P = 0.03) and 
mental component summary (β = 0.22, P = 0.01). Depression is a prevalent psychological 
problem in PD population. Residual renal function is the most important factor associated 
with depression and impaired HRQOL in PD patients.
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INTRODUCTION
Depression is the most widely acknowledged psychological prob-
lem among end-stage renal disease (ESRD) patients (1, 2). About 
28% of chronic kidney disease patients facing impending dialy-
sis have major depression, and even larger proportions of dialy-
sis patients suffer from depression (3). According to the previ-
ous studies, several modifiable risk factors such as anemia, poor 
nutritional status, and high peritonitis rates were reported to be 
associated with depression (4). 
  Depression is a serious problem in ESRD patients not only 
because it is prevalent but also because it is associated with de-
creased health-related quality of life (HRQOL). Since both pa-
tient’s survival rate and technical survival rate have been im-
proved over decades, quality of remaining life in peritoneal di-
alysis (PD) patients became an important issue more than ever. 
In addition, decreased HRQOL per se is related to higher mor-
tality and hospitalization rate (5). Therefore, defining contribut-
ing factors to depression and HRQOL is crucial to properly man-
age them to improve dialysis outcomes in PD patients.
  In Korea, PD population has been steadily increased for sev-
eral years. According to the nation-wide ESRD Registry data from 
Korean Society of Nephrology, approximately 20% of dialysis 
population maintains PD, and about 1,000-2,000 patients start 
PD every year (6). One of the important factor influencing chron-
ic kidney disease patients to favor PD on hemodialysis (HD) is 
that it is known to be better for preserving residual renal func-
tion (RRF) (7, 8). However, the effect of RRF and depression or 
HRQOL has not been elucidated well in previous studies. This is 
a single-center, cross-sectional study designed to evaluate de-
pression and HRQOL among maintenance PD patients and to 
define contributing factors including RRF. 
MATERIALS AND METHODS
Subjects
Total of one hundred and nine maintenance PD patients aged 
over 18 yr from Seoul National University Hospital were screened. 
Four patients refused to enroll, and total of 105 patients were 
enrolled in the study from October 2008 until December 2008. Park HC, et al.  •  RRF, Depression and HRQOL in Korean PD Patients
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They were diagnosed with ESRD and had been on PD for more 
than 6 months. The trained clinical research coordinator (CRC) 
read and filled out the questionnaires for the patients with read-
ing and writing difficulties. 
Data collection
Demographic and laboratory data were obtained from medical 
records. Age, gender, marital status, causes of ESRD, duration of 
dialysis, education level, and religious status were reviewed in 
all patients. The information on job status - employed or unem-
ployed- was also collected. The causes of ESRD were categorized 
into diabetes mellitus, glomerulonephritis, hypertension, others, 
and unknown cause. Patients were classified into two groups 
according to their maximum education level: Up to high school 
graduate or beyond college graduate. Plasma hemoglobin (Hb), 
serum albumin, serum cholesterol, blood urea nitrogen (BUN), 
creatinine, C-reactive protein (CRP), and weekly Kt/Vurea (total, 
renal, and peritoneal Kt/Vurea) were reviewed from laboratory 
reports. The Kt/Vurea is a dimensionless index that measures frac-
tional urea clearance, which comprises a peritoneal and a resid-
ual renal component. In the analysis, patients were classified as 
low Hb (< 10.0 g/dL) vs high Hb (≥ 10.0 g/dL) group. Low albu-
min level was defined as serum albumin  ≤ 4.0 g/dL and high 
CRP was defined as CRP  ≥ 0.5 mg/dL. Plasma Hb, serum albu-
min and normalized protein equivalent of nitrogen appearance 
(nPNA) were checked for nutritional indices. The CRP was mea-
sured as an inflammatory marker. The funding organization had 
no role in the study design, data collection, data analysis, data 
interpretation, or writing the manuscript.
Survey instruments
The Modified Charlson comorbidity Index (MCCI) was used to 
quantify the severity of comorbidity. The MCCI has been com-
monly employed in the studies with ESRD patients and espe-
cially validated in the studies of HRQOL (9). The patients were 
grouped based on the MCCI scores as low (< 5) and high (≥ 6) 
comorbidity groups (10).
  The Korean version of Beck’s Depression Inventory (BDI) was 
used to evaluate depression in our patients. The BDI has been 
validated in various groups of patients and has been used in dial-
ysis patients to evaluate depression (1). The BDI consisted of 21 
self-reported items and each item is rated on the scale of 0-3, 
producing possible score range from 0 to 63 (0 to 4; no depres-
sion, 5 to 9; mild to moderate depression, 10 to 18; moderate to 
severe depression, 19 to 29; and severe depression, 30 to 63) (11). 
We set up a cut-off value of 19 to include patients with moderate 
to severe depression.
  KDQOL-SF
TM has been used to evaluate HRQOL of ESRD pa-
tients (12), and recently, Park et al. translated and validated the 
Korean version of KDQOL-SF
TM (13). It takes less than 20 min 
to complete the questionnaire, which consists of a generic core 
of 36 items supplemented with 43 kidney-disease targeted items 
and one overall health rating item. The detailed explanation about 
the composition of KDQOL-SF
TM is shown in our previous study 
(14). We used the Korean version of KDQOL-SF
TM to measure 
HRQOL in maintenance PD patients. Instruments and scoring 
programs of KDQOL-SF
TM can be found at http://www.gim.
med.ucla.edu/kdqol/downloads/download.html.
Statistical analysis
Data were analyzed using SPSS 16.0 for Windows (SPSS Inc., 
Chicago, IL, USA). We used frequency analysis to evaluate the 
prevalence of depression. The Fisher’s exact test was used to eval-
uate risk factors for depression including demographic and lab-
oratory variables and to compare HRQOL scores between de-
pressed and non-depressed patients. Then, we performed mul-
tiple logistic regression analysis to define independent risk fac-
tors for depression. The linear regression analysis was used to 
show the relationship between BDI score and each component 
score of KDQOL-SF
TM. We also used linear regression analysis 
to define variables associated with each component summary 
score of KDQOL-SF
TM. Then, we performed multiple linear re-
gression analysis to define independent risk factors associated 
with impaired HRQOL. The results were given as mean ± SD 
and P < 0.05 was considered to be statistically significant.
Ethics statement
The institutional review board of Seoul National University Hos-
pital approved the research protocol in September 2008 (IRB 
No. H-0807-053-251). All subjects gave written informed con-
sent before study enrollment.
RESULTS
Baseline characteristics
Table 1 shows baseline demographic characteristics of the sub-
jects. Total 105 patients were included in the study. The mean 
age was 49 yr and male was slightly dominant (52.4%). The av-
erage duration of PD was 48.6 ± 35.7 months. Eighty-six pa-
tients (81.9%) were on continuous ambulatory peritoneal dialy-
sis (CAPD) modality, ten patients (9.5%) on automated perito-
neal dialysis (APD) method, and another 9 patients (8.6%) were 
on intermittent peritoneal dialysis (IPD) method. Most patients 
were married (76.2%) and about two-thirds of patients had reli-
gious belief. Only 34 subjects (32.4%) were employed at the time 
of study. Thirty-eight (36.2%) patients experienced  ≥ 1 episodes 
of peritonitis during their dialysis period, and 15 of them had  ≥ 2 
episodes of peritonitis. The average peritonitis rate was 0.18 ±  
0.36 episodes/year. Diabetes mellitus (32.4%) was the most com-
mon cause of ESRD, followed by glomerulonephritis (29.5%) and 
hypertension (3.8%). Among 101 patients with available weekly 
Kt/Vurea data, total (peritoneal + renal) Kt/Vurea and renal Kt/Vurea Park HC, et al.  •  RRF, Depression and HRQOL in Korean PD Patients
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were 2.06 ± 0.54 and 0.49 ± 0.65, respectively.
Prevalence of depression in PD patients
The mean BDI score was 13.7 ± 8.4 in our patients. Twenty-six 
of 105 (24.8%) patients had moderate to severe depression with 
a cut-off value of 19. When we set up a cut-off value to 10 to de-
tect mild to severe depression, the prevalence of depression in-
creased to the value of 66.7% (70 of 105 patients). The mean BDI 
score of depressive patients was 25.5 ± 5.6, which was significant-
ly higher than that of non-depressed patients (9.9 ± 4.8, P < 0.001, 
Table 1).
Residual renal function as an independent risk factor for 
depression
We evaluated demographic and clinical variables that were as-
sociated with depression (Table 2). In univariate analysis, lower 
weekly renal Kt/Vurea (< 0.2), lower nPNA (< 1.2 g/kg/day) and 
lower serum albumin level (≤ 4.0 g/dL) were associated with 
depression (P < 0.05). However, neither weekly total Kt/Vurea nor 
peritoneal Kt/Vurea was associated with depression. Demographic 
variables including age, gender, marital status, religious status, 
work status and education level did not show significant asso-
ciation with depression. Neither peritonitis rate nor CRP level 
was associated with depression. When we performed multivari-
ate logistic regression analysis, lower renal Kt/Vurea (< 0.2) was the 
only independent risk factor associated with depression (OR =  
3.1, 95% CI [1.12-8.59], P = 0.03). 
Impaired HRQOL in depressed patients
Each component summary of KDQOL: physical component 
summary (PCS), mental component summary (MCS), kidney 
dialysis component summary (KDCS) and subscales were eval-
uated and compared between depressed and non-depressed 
groups (Fig. 1). Among SF-36 domains, depressed patients showed 
significantly lower scores in physical function (PF), role physi-
cal (RP), bodily pain (BP), general health (GH), vitality (VT), role 
emotional (RE) and mental health (MH) domains (P < 0.05). All 
subscales of PCS showed significant difference between groups. 
Among disease-specific KDCS domains, depressed patients 
showed significantly lower scores in symptom/problem (DS), 
Table 1. Baseline characteristics of study population
Variables
Overall 
(n = 105)
Depressed 
(n = 26)
Non- 
depressed 
(n = 79)
P value
BDI score 13.7 ± 8.4 25.5 ± 5.6   9.9 ± 4.8 < 0.001
Age (yr)   49.3 ± 13.6   49.7 ± 12.8   49.1 ± 14.0 0.93
Male, No. (%) 55 (52.4) 14 (53.8) 41 (51.9) > 0.99
Time on PD (months)   48.6 ± 35.7   52.5 ± 46.7   47.3 ± 31.5 0.95
Single or widowed, No. (%) 25 (23.8)   6 (23.1) 19 (24.1) > 0.99
Religious belief, No. (%) 73 (69.5) 17 (65.4) 56 (70.9) 0.63
Unemployed, No. (%) 71 (67.6) 18 (69.2) 53 (67.1) > 0.99
Education status, No. (%)
   Up to high school
   Beyond college
 
54 (51.4)
51 (48.6)
 
37 (46.8)
42 (53.2)
 
17 (65.4)
  9 (34.6)
 
0.12
Peritonitis rates 
   (episodes/yr)
  0.18 ± 0.36   0.12 ± 0.32   0.19 ± 0.38 0.29
MCCI score ( ≥ 6), No. (%) 36 (34.3)   7 (26.9) 29 (36.7) 0.85
nPNA (g/kg/day)*   1.01 ± 0.19   0.94 ± 0.22   1.03 ± 0.17 0.02
Total Kt/Vurea*   2.06 ± 0.54   1.94 ± 0.45   2.09 ± 0.56 0.16
Renal Kt/Vurea*   0.49 ± 0.65   0.27 ± 0.47   0.56 ± 0.69 0.06
Peritoneal Kt/Vurea*   1.64 ± 0.89 1.67 ± 0.5   1.64 ± 0.99 0.44
Hemoglobin (g/dL) 10.6 ± 1.3 10.4 ± 1.4 10.6 ± 1.3 0.52
Albumin (g/dL)   3.7 ± 0.4   3.6 ± 0.3   3.7 ± 0.4 0.39
Creatinine (mg/dL) 10.6 ± 3.7 11.7 ± 3.9 10.3 ± 3.6 0.1
CRP (mg/dL)*   0.23 ± 0.41   0.14 ± 0.23   0.26 ± 0.45 0.65
*Data were analyzed without missing data and extreme values. BDI, Beck’s Depres-
sion Inventory; MCCI, Modified Charlson’s Comorbidity Index; nPNA, normalized pro-
tein equivalent of nitrogen appearance; CRP, C-reactive protein.
Table 2. Variables associated with Beck’s Depression Inventory score
Variables
Univariate Multivariate
Depressed  
(n = 26)
Non-depressed 
(n = 79)
P value Exp (B) (95% CI) P value
Age (yr) ≥ 60   5 (19.2) 22 (27.8) 0.45 - -
Male 14 (53.8) 41 (51.9) > 0.99 - -
Single or widowed   6 (23.1) 19 (24.1) > 0.99 - -
No religion   9 (34.6) 23 (29.1) 0.63 - -
Unemployed 18 (69.2) 53 (67.1) > 0.99 - -
Low educational status (Up to high School) 17 (65.4) 37 (46.8) 0.12 - -
Diabetes mellitus   7 (26.9) 28 (35.4) 0.48 - -
Hypertension 22 (84.6) 64 (81.0) 0.78 - -
MCCI score  ≥ 6   7 (26.9) 29 (36.7) 0.48 - -
nPNA (g/kg/day)  < 1.2   23 (100.0) 61 (81.3) 0.04 5.60 (0.67-47.1) 0.11
Weekly total Kt/Vurea  < 1.7   9 (36.0) 16 (21.1) 0.18 - -
Weekly renal Kt/Vurea  < 0.2 18 (72.0) 35 (46.1) 0.04 3.10 (1.12-8.59) 0.03
Hemoglobin (g/dL)  < 10   9 (34.6) 21 (26.6) 0.46 - -
Albumin (g/dL)  ≤ 4.0   26 (100.0) 67 (84.8) 0.04 - > 0.99
CRP (mg/dL)  ≥ 0.5   2 (11.8)   7 (14.6) > 0.99 - -
MCCI, Modified Charlson’s Comorbidity Index; nPNA, normalized protein equivalent of nitrogen appearance; CRP, C-reactive protein.Park HC, et al.  •  RRF, Depression and HRQOL in Korean PD Patients
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effects of kidney disease (DE), burden of kidney disease (DB), 
cognitive function (CF), quality of social interaction (SI), sleep 
(SL) and social support (SS) domains (P < 0.05). However, scores 
related to patient satisfaction domains (staff encouragement 
[SE] and patients satisfaction [PS]) were not different between 
groups. The mean ± SD for PCS, MCS, and KDCS in depressed 
group were lower compared to those in non-depressed group 
(45.2 ± 14.1 vs 61.2 ± 16.8, 41.8 ± 14.2 vs 58.3 ± 17.5 and 51.7 ±  
10.8 vs 64.1 ± 10.5, respectively, P < 0.001). When we performed 
linear regression analysis, the BDI score was negatively corre-
lated with each component summary score and its association 
was statistically significant (P < 0.001, Fig. 2).
Residual renal function as an independent risk factor for 
impaired HRQOL
We evaluated the relationship between clinical variables and 
each component summary of KDQOL: PCS, MCS, and KDCS 
(Table 3). In univariate analysis, the nPNA level (β = 0.15, P =  
0.03) and weekly renal Kt/Vurea (β = 0.24, P = 0.005) were closely 
related to KDCS, whereas plasma Hb was associated with both 
PCS (β = 0.22, P = 0.03) and MCS (β = 0.22, P = 0.01). Female pa-
tients were more likely to have better quality of life in MCS di-
mension than male patients with marginal statistical significance 
(β = 0.22, P = 0.05). Patients with lower weekly renal Kt/Vurea 
showed lower MCS score with marginal statistical significance 
(β = 0.10, P = 0.06). When we performed multiple linear regres-
sion analysis, weekly renal Kt/Vurea was the only independent risk 
factor associated with KDCS (β = 0.24, P = 0.02). On the other 
hand, weekly peritoneal Kt/Vurea, which reflects peritoneal sol-
ute removal, did not correlate with any of HRQOL dimensions. 
Plasma Hb was the independent risk factor for both PCS (β = 0.22, 
P = 0.03) and MCS (β = 0.26, P = 0.01), whereas female gender 
was another independent risk factor for HRQOL in MCS dimen-
sion (β = 0.22, P = 0.03). 
DISCUSSION
In this single-center, cross-sectional study, we evaluated the prev-
alence of depression among maintenance PD patients and re-
vealed associated factors with depression and HRQOL. Among 
our patients, 26 (24.8%) patients showed moderate to severe 
depression. Lower weekly renal Kt/Vurea and the nutritional in-
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Fig. 1. Comparison of KDQOL-SF
TM scores between depressed and non-depressed 
patients. *P < 0.05; 
†P < 0.01. (A) SF-36 domain scores (PF, Physical function; RP, 
Role physical; BP, Bodily pain; GH, General health; VT, Vitality; SF, Social function; RE, 
Role Emotional; MH, Mental health). (B) Disease-specific domain scores (DS, Symp-
tom problem; DE, Effects of kidney disease; DB, Burden of kidney disease; WS, Work 
status; CF, Cognitive function; SI, Quality of social interaction; SF, Sexual function; SL, 
Sleep; SS, Social support; SE, Staff encouragement; PS, Patient satisfaction). (C) Com-
posite summary scores (physical component summary [PCS], mental component sum-
mary [MCS], and kidney disease component summary [KDCS]).
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dices were closely related to depression and HRQOL. Among 
them, lower RRF was the independent risk factor for depression 
and impaired HRQOL in our PD patients. 
  Depression and associated factors have been studied widely 
among dialysis patients. However, very few have been focused 
on the depression in PD population. In our study, about one-
fourth of patients were found to have depression defined by BDI 
score over 19. This is slightly less than the prevalence of depres-
sion in maintenance HD patients in our previous study (51 of 
160 subjects, 31.9%) (14). The exact comparison is beyond our 
scope because they were not analyzed at the same time with 
proper adjustment. However, some remarks can be made on 
the present analysis. At first, previous studies showed that pa-
tients on PD were more likely to preserve RRF than HD popula-
tion (7, 15). According to our study, depressed patients showed 
lower RRF. Therefore, RRF must have some implication in the 
prevalence of depression according to dialysis modality. Further 
research should be done to reveal their association. Second, we 
clinically evaluated depression using the cut-off value of BDI 
score 19, and therefore, we might not have precisely diagnosed 
Table 3. Regression models to explain variables associated with each component summary score of KDQOL-SF
TM [as Standardized Regression Coefficient β (Partial R
2) and     
Total R
2]*
Variables PCS P value MCS P value KDCS P value
Female - - 0.22 (3.7%) 0.05 - -
nPNA - - - - 0.15 (4.7%) 0.03
Hemoglobin  0.22 (4.7%) 0.03 0.22 (6.3%) 0.01 - -
Renal Kt/Vurea - - 0.10 (3.4%) 0.06 0.24 (8.0%)   0.005
Total R
2 4.7% - 12.1% - 10.1% -
*β denotes the relative importance of the explaining variable: the higher the β coefficient, the higher the contribution of that variable in the regression equation. Partial R
2 sym-
bolizes the explained variance of the dependent variable accounted for by the variable. Total R
2 is the percentage of the total variation of the HRQOL score that is explained by 
the independent risk factors together. PCS, Physical Component Summary; MCS, Mental Component Summary; KDCS, Kidney Dialysis Component Summary; nPNA, normalized 
protein equivalent of nitrogen appearance.
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‘pathologic’ depression. According to the previous study, how-
ever, cut-off scores ranging from  ≥ 14 to 16 compare well with 
diagnostic assessments of depression in dialysis patients (16). 
Therefore, although our BDI criteria may have underestimated 
the prevalence of depression, those who were detected as ‘de-
pressed’ are a high-risk group of patients who need an active 
management.
  Depression can affect medical outcomes through a variety of 
mechanism. It can alter patient’s ability to utilize medical care or 
change the behavior (17). Depression also increases hospital-
ization and mortality rates (18-20). One interesting study exam-
ined the effect of sertraline hydrochloride, an anti-depressant, 
in PD patients with clinical depression (21). After 12-week of 
treatment period, sertraline hydrochloride not only improved 
BDI score but also improved HRQOL and symptoms related to 
depression among PD patients. Therefore, the diagnosis and 
treatment of clinical depression in chronic PD patients are enor-
mously important to improve their HRQOL. In our practice, how-
ever, referral to the psychiatric department is rarely done because 
either patients deny their depressed mood or refuse to visit psy-
chiatry office or few practitioners have an interest in patients’ 
mood. If we appropriately treat these patients with medication, 
it is more likely to improve their HRQOL and medical outcome. 
  This is the first study in Korea to demonstrate that RRF and nu-
tritional status are important factors for depression and HRQOL 
in PD patients. In the previous study, Kim et al. analyzed depres-
sion in PD patient for the first time in Korea (22). They used Ko-
rean Center for Epidemiologic Studies Depression (CES-D) to 
evaluate depression. However, the prevalence of depression in 
their study was 75%, which is too much higher than the value 
(20%-30%) reported in many other studies (1, 23). In addition, 
they focused on the psychosocial issue such as stress and sense 
of hopelessness as risk factors for depression. They did not in-
clude either RRF or nPNA as potential variables. Since the num-
ber of incident PD patients is increasing every year and the aver-
age life span of dialysis patients has increased, we think our study 
is valuable because we emphasized the impact of depressive 
mood on HRQOL and evaluated its related factors. 
  In our study, lower weekly renal Kt/Vurea was the independent 
risk factor for depression and impaired HRQOL in PD patients. 
To the best of our knowledge, there is no study performed on 
the relationship between depression and RRF in PD population. 
One study compared weekly total Kt/Vurea between depressed 
and non-depressed patients and showed there was no statisti-
cally significant difference between groups (n = 43 vs n = 38, 
1.8 ± 0.1 vs 1.9 ± 0.1, P > 0.05) (24). However, current concept of 
dialysis adequacy has been changed since a number of studies 
showed that RRF is more important than peritoneal clearance 
in the prognosis of PD patients (25, 26). Therefore, the result of 
our study implicates that preservation of renal function is im-
portant to decrease depressive symptoms other than increasing 
the dialysis dose. Meanwhile, the preservation of RRF has been 
suggested to improve HRQOL in both hemodialysis and perito-
neal dialysis patients. In the CHOICE study, Shafi et al. demon-
strated that preserved residual urine output was associated with 
better survival and QOL, lower inflammation and less erythro-
poietin use in hemodialysis patients (27). In addition, Termor-
shuizen et al. demonstrated in their 2-yr prospective study that 
RRF was more important than peritoneal clearance for PD pa-
tient survival and HRQOL (25). They used residual glomerular 
filtration rate (rGFR) to show RRF as an important determinant 
of HRQOL. However, when they repeated the same analysis with 
weekly renal Kt/Vurea instead of rGFR, the beneficial effect was 
restricted to the bodily pain and sleep disorder dimension. In 
our study, weekly renal Kt/Vurea was an independent risk factor 
for KDCS, not PCS or MCS dimension. Further large-scale, pro-
spective studies are warranted to demonstrate the effect of RRF 
preservation on the maintenance or improvement of HRQOL 
in PD patients. 
  On the other hands, nutritional indices including nPNA, serum 
albumin, and plasma Hb were also demonstrated as important 
factors associated with depression and HRQOL. Nutritional sta-
tus, usually evaluated by the Subjective Global Assessment and 
serum albumin, has been reported to be closely associated with 
depression and HRQOL (28-30). Recently published data showed 
that depression can cause a chronic inflammatory state in the 
body system, which can increase the cardiovascular risk and 
mortality in dialysis patients. They suggested that depression 
may be related to a high mortality rate and it should be under-
stood in the context of the malnutrition-inflammation-athero-
sclerosis (MIA) syndrome (24). Our study result is in the concor-
dance with the previous study results. However, we could not 
demonstrate the relationship with depression and inflammato-
ry marker such as CRP level. We assume that it may be related 
to the small sample size. Only 65 patients were included with 
available CRP data. Besides, most of our patients showed normal 
range of CRP level (0.23 ± 0.41 mg/dL). Future study is needed 
to disclose mechanism underlying the MIA syndrome and de-
pression.
  There are some limitations to our study. At first, this is a single-
center, observational study with a small-size population. The 
result of our study should be confirmed in the large-scale, multi-
center study in the future. Second, the result may be biased be-
cause not all the PD patients in our center were enrolled in our 
study. Those who refused to enroll in the study could have more 
depressive symptoms that prevented them from actively engage 
in the study. At last, there were many missing data, especially 
for nPNA and CRP, which must have led to the biased results. 
Although there are some limitation in the study design and pa-
tient enrollment, this study is invaluable to reveal RRF as an im-
portant determinant of HRQOL in PD patients.
  In conclusion, depression is the prevalent psychological prob-Park HC, et al.  •  RRF, Depression and HRQOL in Korean PD Patients
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lem among maintenance PD patients. Lower RRF is an indepen-
dent risk factor associated with depression and HRQOL in PD 
patients. The clinicians should be aware of clinical importance 
of RRF in the management of PD patients.
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